Insight Medbotics is featured in the Medtech Strategist’s February 2024 issue as a Start-Up to Watch.
“Insight Medbotics: Operating Robotically Inside the MRI” by Colin Miller includes interviews with CEO Fazila Seker and Co-Founder Dr. Mehran Anvari, who also sits on the Clinical Advisory Board.
Download a pdf copy of the Medtech Strategist article.
The article covers Fazila Seker’s appointment and CEO, recent FDA 510(k) approval in breast biopsy, and the company’s pivot toward partnering with AI and imaging companies to bring this technology to explore other biopsy applications (such as prostate) and drug delivery models.
It also covers Insight Medbotics’ origins and partnerships with MDA and the Centre for Surgical Invention and Innovation (CSii).
